`U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)
[ X ]  Quarterly  Report  Pursuant  to  Section  13 or 15(d)  of the  Securities
Exchange Act of 1934

For the quarterly period ended June 30, 2003

Transition Report Pursuant to 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from __________ to __________

Commission file number: 333-85460

                          Vibrant Health International
        (Exact Name of Small Business Issuer as Specified in Its Charter)

              Nevada                                   84-1595734
   (State or other jurisdiction of                  (I.R.S. Employer
    incorporation of organization)                 Identification No.)

                8907 E. Chenango Ave, Greenwood Village, CO 80111
               (Address of principal executive offices) (Zip Code)

                     Issuer's telephone number: 303-713-1870

(Former Name, Former Address and Former Fiscal Year, If Changed Since Last Report)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. Yes  X   No
                                                              ---     ---

As of June 30,  2003,  the  registrant  had  4,360,600  shares of  common  stock
outstanding.

Transitional Small Business Disclosure Format (Check one): Yes     No  X
                                                               ---    ---


                                   FORM 10-QSB
                          VIBRANT HEALTH INTERNATIONAL
                          (A Development Stage Company)


                                      INDEX


PART I.    Financial Information

           Item 1.  Consolidated Financial Statements

           Consolidated Balance Sheet as of June 30, 2003
           (unaudited) and December 31, 2002

           Unaudited Consolidated Statements of Operations for the
           Three and Six Months ended June 30, 2003 and 2002 and the
           period from December 3, 1997 (inception) through June 30,
           2003

           Unaudited Consolidated Statement of Stockholders' Equity
           for the period from December 3, 1997 (inception) through
           June 30, 2003

           Unaudited Consolidated Statements of Cash Flows for the
           Six Months ended June 30, 2003 and 2002 and the period from
           December 3, 1997 (inception) through June 30, 2003

           Notes to Unaudited Consolidated Financial Statements

           Item 2.  Management's Discussion and Analysis or Plan
           of Operation

           Item 3.  Controls and Procedures

PART II.   Other Information

           Item 1.  Legal Proceedings

           Item 2.  Changes in Securities and Use of Proceeds

           Item 6.  Exhibits and Reports on Form 8-K

           Signatures

(Inapplicable items have been omitted)


PART I.

Financial Information

Item 1.  Consolidated Financial Statements (unaudited)

In the opinion of management,  the accompanying unaudited consolidated financial
statements included in this Form 10-QSB reflect all adjustments (consisting only
of normal recurring  accruals)  necessary for a fair presentation of the results
of  operations  for the periods  presented.  The results of  operations  for the
periods  presented are not necessarily  indicative of the results to be expected
for the full year.



          VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                          (a Development Stage Company)

                           Consolidated Balance Sheet


                                                             June 30,       December 31,
                                                               2003            2002
                                                           -------------    ------------
                                                           (unaudited)
                                     Assets

Current assets
  Cash                                                      $     29,516    $     49,028
                                                            ------------    ------------

Total assets                                                $     29,516    $     49,028
                                                            ============    ============

                      Liabilities and Stockholders' Equity
Current liabilities
  Accounts payable and accrued expenses                     $      5,039    $      1,891
                                                            ------------    ------------
   Total current liabilities                                       5,039           1,891
                                                            ------------    ------------

Commitments and contingencies

Stockholders' equity
  Common stock, authorized 100,000,000 shares, $.001
   par value; 4,360,600 shares issued and outstanding              4,361           4,361
  Additional paid-in capital                                     110,009         110,009
  Deficit accumulated during the development stage               (89,893)        (67,233)
                                                            ------------    ------------
   Total stockholders' equity                                     24,477          47,137
                                                            ------------    ------------

Total liabilities and stockholders' equity                  $     29,516    $     49,028
                                                            ============    ============




                 Unaudited Consolidated Statements of Operations


                                                                                 For the
                                                                                 Period
                                                                                  from
                                                                                December 3,
                            For the Three Months                                  1997
                                    Ended            For the Six Months Ended  (Inception)
                          -------------------------  ------------------------    through
                            June 30,     June 30,     June 30,     June 30,     June 30,
                              2003         2002         2003         2002         2003
                          -----------   -----------  -----------  -----------  -----------
                          (unaudited)   (unaudited)  (unaudited)  (unaudited)  (unaudited)

Sales                      $    8,685    $    3,813   $   12,994   $    3,813   $   41,153

Cost of goods sold              2,821         1,360        3,858        1,360       13,539
                           ----------    ----------   ----------   ----------   ----------

Gross profit                    5,864         2,453        9,136        2,453       27,614
                           ----------    ----------   ----------   ----------   ----------

Operating expenses
  Website development
   costs                            -         2,209            -        2,209       13,844
  General and
   administrative
   expenses                    13,365        10,581       31,989       18,141       99,197
                           ----------    ----------   ----------   ----------   ----------
      Total operating
       expenses                13,365        12,790       31,989       20,350      113,041
                           ----------    ----------   ----------   ----------   ----------

Loss from operations           (7,501)      (10,337)     (22,853)     (17,897)     (85,427)

Interest expense                    -          (900)           -       (2,800)      (4,747)
Interest income                    86             -          193                       281
                           ----------    ----------   ----------   ----------   ----------

Net loss                   $   (7,415)   $  (11,237)  $  (22,660)  $  (20,697)  $  (89,893)
                           ==========    ==========   ==========   ==========   ==========

Earnings (loss) per
 share - basic and
 diluted                   $   (0.002)   $   (0.003)  $   (0.005)  $   (0.005)
                           ==========    ==========   ==========   ==========

Weighted average shares
 outstanding                4,360,600     3,935,000    4,360,600    3,935,000
                           ==========    ==========   ==========   ==========




            Unaudited Consolidated Statement of Stockholders' Equity
     For the Period from December 3, 1997 (Inception) through June 30, 2003


                                                                Deficit
                                                              Accumulated
                               Common Stock       Additional   During the      Total
                           ---------------------   Paid-In    Development   Stockholders'
                            Shares      Amount     Capital       Stage        Equity
                           ---------   ---------   ---------   ----------    ----------
Balance - December 3,
 1997 (Inception)                 -    $      -    $      -    $       -     $       -

Stock issued                 970,000         970          -            -            970

Net loss for periods              -           -           -          (897)         (897)
                           ---------   ---------   ---------   ----------    ----------

Balance - December 31,
 2000                        970,000         970          -          (897)           73

Stock issued               2,965,000       2,965       4,035           -          7,000

Net loss                          -           -           -       (25,128)      (25,128)
                           ---------   ---------   ---------   ----------    ----------

Balance - December 31,
 2001                      3,935,000       3,935       4,035      (26,025)      (18,055)

Stock issued                 425,600         426     105,974           -        106,400

Net loss                          -           -           -       (41,208)      (41,208)
                           ---------   ---------   ---------   ----------    ----------

Balance - December 31,
 2002                      4,360,600       4,361     110,009      (67,233)       47,137

Net loss                          -           -           -       (22,660)      (22,660)
                           ---------   ---------   ---------   ----------    ----------

Balance - June 30, 2003    4,360,600   $   4,361   $ 110,009   $  (89,893)   $   24,477
                           =========   =========   =========   ===========   ==========



                 Unaudited Consolidated Statements of Cash Flows


                                                                               For the
                                                                             Period from
                                                                             December 3,
                                                                                 1997
                                                For the Six Months Ended      (Inception)
                                              ----------------------------     through
                                                June 30,       June 30,        June 30,
                                                  2003           2002            2003
                                              ------------   -------------   -------------
                                              (unaudited)    (unaudited)     (unaudited)
Cash flows from operating activities
  Net loss                                    $    (22,660)  $     (20,697)  $     (89,893)
  Adjustments  to reconcile net loss to net
  cash used in operating activities
   Common stock issued for interest expense             -               -              750
   Changes in operating assets and
    liabilities
     Accounts payable and accrued expenses           3,148           2,227           5,039
                                              ------------   -------------   -------------
      Net cash used in operating activities        (19,512)        (18,470)        (84,104)
                                              ------------   -------------   -------------

Cash flows from financing activities
  Proceeds from issuance of common stock                -               -          113,620
                                              ------------   -------------   -------------
      Net cash provided by financing
       activities                                       -               -          113,620
                                              ------------   -------------   -------------

Net (decrease) increase in cash                    (19,512)        (18,470)         29,516

Cash, beginning of year                             49,028          23,009               -
                                              ------------   -------------   -------------

Cash, end of period                           $     29,516   $       4,539   $      29,516
                                              ============   =============   =============



              Notes to Unaudited Consolidated Financial Statements


Note 1 - Organization and Summary of Significant Accounting Policies

Vibrant  Health  International  (the  Company),  was formed on July 9, 2001 as a
Nevada company.  The Company's  business  operations and contracts are primarily
conducted by its wholly owned subsidiary, Vibrant Health, Inc.

Vibrant  Health,  Inc.  was formed on  December  3, 1997 as a Colorado  company.
Vibrant  Health,  Inc. is a supplier and  distributor of health and  nutritional
products via use of the Internet. Operations since inception consist principally
of setting up the Company,  developing the Company's websites,  and commencement
of initial product sales.

On July 9, 2001, the Company issued 2,910,000 shares of common stock in exchange
for 100% of the  outstanding  shares of Vibrant  Health,  Inc. Due to the common
ownership  of  the   companies,   the   acquisition   was  accounted  for  as  a
recapitalization of Vibrant Health, Inc.



Note 2 - Liquidity and Management's Plans

The Company has incurred  accumulated  losses of approximately  $90,000 from the
inception of Vibrant Health  International  through June 30, 2003.  These losses
and the significant future cash requirements  related to developing the business
indicate  substantial  doubt that the Company may be able to continue as a going
concern unless additional  capital is obtained or future  profitable  operations
are achieved.

During 2002, the Company completed a Form SB-2 Registration  Statement under the
Securities  Act of 1933.  The  offering  was  closed in  October  2002 and total
proceeds of $106,400 were released to the Company from escrow. In the opinion of
management,  with the resources currently available, the Company will be able to
maintain its operations through June 30, 2004.



Item 2. Management's Discussion and Analysis or Plan of Operation

FORWARD-LOOKING STATEMENTS

This  Quarterly  Report  on Form  10-QSB  contains  forward-looking  statements.
Additional written or oral forward-looking statements may be made by the Company
from time to time in filings  with the  Securities  and Exchange  Commission  or
otherwise.  The words  "believe,"  "expect,"  "seek," and  "intend"  and similar
expressions identify forward-looking statements, which speak only as of the date
the statement is made. Such forward-looking statements are within the meaning of
that term in Section 27A of the Securities Act of 1933, as amended,  and Section
21E of the  Securities  Exchange Act of 1934, as amended.  Such  statements  may
include,  but are not limited to,  projections of income or loss,  expenditures,
acquisitions,  plans for future operations, financing needs or plans relating to
services of the  Company,  as well as  assumptions  relating  to the  foregoing.
Forward-looking  statements are inherently  subject to risks and  uncertainties,
some of which  cannot be  predicted  or  quantified.  Future  events  and actual
results  could differ  materially  from those set forth in,  contemplated  by or
underlying the forward-looking statements.

The Company does not undertake,  and specifically  disclaims,  any obligation to
publicly release the results of revisions,  which may be made to forward-looking
statements to reflect the occurrence of anticipated or  unanticipated  events or
circumstances after such statements.

General

We were  incorporated  in Nevada on July 9, 2001. We are a distributor of health
and nutritional  products.  We have commenced only limited  operations as of the
date of this filing.  Currently,  we are distributing healthcare products to our
customers     via    orders     generated    on    our    Internet     websites,
www.vibranthealthonline.com and www.yahoovibranthealth.com. Our current business
operations and related operational contracts  are being  conducted by our wholly
owned subsidiary, Vibrant Health, Inc., a Colorado corporation.

Our Business

We distribute  health and nutritional  products.  We are a distribution  company
only and do not have any expertise in nutritional science or manufacturing.  The
name Vibrant  Health does not reflect  health  expertise but rather is marketing
oriented,  and was  selected  to  instill in our  customers  a feeling of vigor,
energy,  and  motivation,  with the clarifying  word of health  pinpointing  our
product focus.  We believe that  individuals  with such feelings will understand
the value of fitness and appreciate the value of our products.

We are focusing our initial marketing efforts in generating sales orders through
our  Internet  websites.   Our  websites   are  www.vibranthealthonline.com  and
www.yahoovibranthealth.com.  We will  accept  ancillary  orders  when  they  are
available  to us by  facsimile,  email,  phone  calls,  or  mail.  However,  our
promotional  materials  generally  advocate and guide the potential  customer to
route  orders  for  our  product  via  our  websites.  Our  websites  are  fully
operational, however, we intend to continuously update and refine our websites.

We do not  manufacture  the products  that we sell.  Instead,  we contract  with
health and nutritional product formulators who specialize in supplying products.
Our plan, as order volume increases, will be to out-source our order fulfillment
operations so that we can focus on the marketing and sale of our products.

We have  entered  into a five-year  agreement  that  expires  October  2006 with
Imagenetix,  Inc., a company located in southern  California,  to supply us with
their  proprietary  products.  They have  experience  in packaging and supplying
health and  nutritional  products.  They will assist us in choosing a few select
products of theirs that they believe are their highest  quality  products,  with
large  potential  markets,  and with  profit  margins  that  would  warrant  our
attention.

We selected  Imagenetix,  Inc. because they are established in the nutrition and
natural health product area. If we were to lose this agreement with  Imagenetix,
Inc., our ability to obtain a supply of quality product on favorable terms would
probably  be greatly  hampered.  We believe  that we would be able to find other
suppliers,  but that they would require a greater expenditure of management time
and that profit margins on sales may decrease.

Our  websites  currently  list  two  products  for  sale.  Each  is  a  form  of
Imagenetix's  proprietary  product,  Celadrin(R).  We  market  a  cream  form of
Celadrin(R)in  a jar and an oral capsules  form of this product in a bottle.  We
place a label on each product  sold  identifying  the product as either  Vibrant
Creme or Vibrant  Celcaps.  We have no exclusivity  with respect to any of these
products.  In fact,  there are several  distributors  that market other  private
label forms of these products through their marketing  organizations.  It is our
understanding  that we are  the  first  E-commerce  company  to be  distributing
Celadrin(R).

Celadrin(R)is a scientifically  tested  formulated  product developed to provide
support  for healthy  joint  function  and  mobility.  Celadrin(R)consists  of a
complex  of  scientifically  targeted  fatty  acid  esters.  The  oral  form  of
Celadrin(R)was  subjected to clinical studies. The results of one of the studies
were  published  in the August,  2002 issue of The Journal of  Rheumatology.  We
intend to  capitalize  on what we  believe  will be a surge of demand  for these
products as new information is released on Celadrin(R)in the near future.

We are supplying products under our own Vibrant Health brand name. Imbedding the
Vibrant Health name as part of the product title may significantly  increase the
name  recognition of both the product and the Company and assist the customer to
associate it with quality and value.  Costs  associated  with labeling  products
with our name are  minimal  and  consist of  printing  new  labels  for  product
containers.

Three Month periods Ended June 30, 2003 and 2002

The Company had $8,685 in sales for the three month  period  ended June 30, 2003
and sales of $3,813 for the same  three-month  period in 2002. Sales were higher
in the quarter  ended June 30, 2003 because the Company  commenced  sales in the
4th  quarter of 2001 and have slowly been  increasing  over time.  Cost of goods
sold was $2,821 for the  three-month  period  ended June 30,  2003  compared  to
$1,360 for the same period in 2002. The Company had a gross profit of $5,864 for
the three months  ended June 30, 2003  compared to $2,453 for the same period in
2002.

Operating  expenses  for the three month period ended June 30, 2003 were $13,365
compared to $12,790 for the same period in 2002.  Expenses  consisted of general
corporate  administration,  legal  and  professional  expenses,  accounting  and
auditing costs and wages.  Increased expenses for the period ended June 30, 2003
were primarily due to wages and  professional  fees. The Company has no interest
expense for the three months  ended June 30, 2003  compared to $900 for the same
period in 2002 because the Company paid off all of its long-term debt in 2002.

As a result of the foregoing factors,  the Company realized a net loss of $7,415
for the three  months ended June 30, 2003 as compared to net loss of $11,237 for
the same period in 2002.

Six Month periods Ended June 30, 2003 and 2002

The Company had  $12,994 in sales for the six month  period  ended June 30, 2003
and sales of $3,813 for the same six-month  period in 2002. Sales were higher in
2003  because  the Company  commenced  sales in the 4th quarter of 2001 and have
slowly  been  increasing  over  time.  Cost of  goods  sold was  $3,858  for the
six-month  period ended June 30, 2003  compared to $1,360 for the same period in
2002. The Company had a gross profit of $9,136 for the six months ended June 30,
2003 compared to $2,453 for the same period in 2002.

Operating  expenses  for the six month  period  ended June 30, 2003 were $31,989
compared to $20,350 for the same period in 2002.  Expenses  consisted of general
corporate  administration,  legal and professional  expenses, and accounting and
auditing costs and wages.  Increased expenses for the period ended June 30, 2003
were  primarily  due to an increase in health  insurance  and an increase in the
professional  fees  related to being a public  company  versus a  privately-held
company.  The Company has no interest  expense for the six months ended June 30,
2003 compared to $2,800 for the same period in 2002 because the Company paid off
all of its long-term debt in 2002.

As a result of the foregoing factors, the Company realized a net loss of $22,660
for the six months  ended June 30,  2003 as  compared to net loss of $20,697 for
the same period in 2002.

Liquidity and Capital Resources

At June 30, 2003, the Company had assets  consisting of $29,516 of cash on hand.
Current  liabilities  consisted  of accounts  payable  and  accrued  expenses of
$5,039. The Company does not have any long-term capital commitments.

The Company  believes  that its  current  cash needs can be met with the cash on
hand and from the proceeds of its initial public  offering.  The offering closed
in October 2002 and generated  proceeds of $106,400.  Proceeds remaining at June
30, 2003 were $8,177.  Should the Company find it necessary to raise  additional
capital,  the Company  may sell  common  stock of the Company or enter into debt
financing agreements.


Item 3. Controls and Procedures

The Company, under the supervision of the chief executive and financial officer,
has conducted an evaluation of the  effectiveness of the design and operation of
the Company's  disclosure  controls and procedures  within 90 days of the filing
date of this quarterly  report.  Based upon the results of this evaluation,  the
Company believes that they maintain proper  procedures for gathering,  analyzing
and  disclosing  all  information  in a timely  fashion  that is  required to be
disclosed in its Exchange Act reports. There have been no significant changes in
the Company's controls subsequent to the evaluation date.


Part II: OTHER INFORMATION

Item 1. Legal Proceedings

The  Company is not a party  defendant  in any  material  pending or  threatened
litigation  and to its  knowledge,  no  action,  suit or  proceedings  has  been
threatened against its officers and its directors.

Item 2.  Changes in Securities and Use of Proceeds

On July 9, 2001, we issued 100,000  shares to our founder and President,  Thomas
H. McAdam in exchange for $1,000 cash and we issued 2,109,000 shares in exchange
for 703,000  shares of Vibrant  Health,  Inc.,  and we issued 750,000 shares for
consideration of making a loan of $15,000  accessible by the Company,  which was
valued at $750.  The  securities  were  sold in  private  transactions,  without
registration  in  reliance  on the  exemption  provided  by Section  4(2) of the
Securities Act. The investor had access to all material  information  pertaining
to the Company and its financial condition.  The investor completed and signed a
subscription  agreement  attesting to his sophistication or accredited  investor
status and investment  intent.  No broker was involved and no  commissions  were
paid in the transactions.

On July 9, 2001, we issued 801,000 shares to a shareholder in exchange for their
267,000  shares of  Vibrant  Health,  Inc.  The stock  was  valued at $801.  The
securities were sold in private  transactions,  without registration in reliance
on the exemption  provided by Section 4(2) of the Securities  Act. Each investor
had  access  to all  material  information  pertaining  to the  Company  and its
financial condition. Each investor completed and signed a subscription agreement
attesting to his  sophistication  or accredited  investor  status and investment
intent. No broker was involved and no commissions were paid in the transactions.

Mr. Thomas McAdam thereafter  purchased 550,000 shares of the newly issued stock
from one of those  shareholders  in a private  transaction,  thus,  bringing Mr.
Thomas McAdam's total  ownership to 3,509,000  shares and reducing the other two
shareholders'  total to a combined 251,000 shares. The shares were purchased for
$550.00 on August 27, 2001.

In September  2001, we issued  175,000  shares of common stock to two accredited
investors  for  a  total  of  $5,250.   The  securities  were  sold  in  private
transactions,  without  registration  in reliance on the  exemption  provided by
Section 4(2) of the  Securities  Act.  Each  investor had access to all material
information pertaining to the Company and its financial condition. Each investor
completed and signed a subscription agreement attesting to his sophistication or
accredited  investor status and investment intent. No broker was involved and no
commissions were paid in the transactions.

The  Company  filed  an SB-2  Registration  Statement  with the  Securities  and
Exchange  Commission  offering  a minimum  of  350,000  shares  and a maximum of
800,000 shares at $0.25 per share.  The offering  became  effective on August 2,
2002 and closed on October 22,  2002.  The Company  successfully  completed  the
offering  of 425,600  shares of common  stock to 44  shareholders  and  received
proceeds  of  $106,400.   The  Company  incurred   expenses  in  the  amount  of
approximately $25,000 relating to the Registration  Statement.  Expenses include
legal fees,  accounting fees,  escrow fees,  filing fees,  printing and transfer
agent costs.  The Company also repaid loans of $40,000 together with interest of
$3,998. There were no underwriters'  discounts,  commissions or finders' fees. A
table detailing the use of proceeds through June 30, 2003 is provided below.

Use of Proceeds                                             Amount

Debt Repayment                                             $40,000
Interest on Loans                                           $3,998
Legal Fees                                                 $10,561
Accounting and Professional Fees                           $14,280
Wages                                                      $15,750
Website and Marketing                                       $4,877
Various working capital items                               $8,757

Total Proceeds Expended                                    $98,223

Balance of Proceeds Remaining                               $8,177


Item 6. Exhibits and Reports on Form 8-K

Reports on Form 8-K:

No reports on Form 8-K were filed by  Vibrant  Health  International  during the
three months ended June 30, 2003.

Exhibits:

Exhibit
Number          Title                                                Location

31              Certification of the Chief Executive Officer and        Attached
                Chief Financial Officer pursuant to 18 U.S.C.
                Section 1350, as adopted pursuant to Section 302 of
                the Sarbanes-Oxley Act of 2002

32              Certification of the Chief Executive Officer and        Attached
                Chief Financial Officer pursuant to 18 U.S.C.
                Section 1350, as adopted pursuant to Section 906 of
                the Sarbanes-Oxley Act of 2002


                                   SIGNATURES


Pursuant to the  requirements of the Securities  Exchange Act of 1934, this Form
10-QSB Report, for the Quarter ended June 30, 2003, has been signed below by the
following person on behalf of the Registrant and in the capacity and on the date
indicated.



                                               VIBRANT HEALTH INTERNATIONAL

August 5, 2003                              By  /s/Thomas H. McAdam
                                                Thomas H. McAdam
                                                Chief Executive Officer and
                                                Chief Financial Officer`